Innovotech (IOT.V) Stock Price

Innovotech Price

CLOSED
0.06
​
Market closed

Revenue has compounded at 8.8% per year over the past 19 years to 4.53 M CAD. Earnings per share have declined at 26.8% per year over the last 8 years. Innovotech's net margin stands at 2.1%, down from 24.8% several years earlier.

Innovotech stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Innovotech business model & stock analysis

Innovotech Inc. generates revenue through the sale of proprietary assay kits, including MBEC Assay Kits, Order Biofilm Assays, and Coated MBEC Assay Lids, which are used in microbial biofilm research. The company also provides contract research services such as Antimicrobial Contract Research, Antimicrobial and Anti-Biofilm Agents testing (MIC and MBEC), and Customized Antimicrobial Testing (BEST Assay Testing and Implanted Medical Device Testing). Its antimicrobial silver products, AgreGuard-1 Silver Antimicrobial for Crop Protection and InnovoSIL Antimicrobial Silver Products, are sold to customers in agricultural and medical sectors. The firm targets research institutions, agricultural producers, and medical device manufacturers seeking biofilm and antimicrobial testing solutions. Innovotech's intellectual property portfolio supports its contract research services, which include testing for antimicrobial agents and materials under standards like TM100, ISO 22196, and USP 51. The company’s Biofilm Publications and SEM Library serve as additional resources for clients engaged in biofilm research. Its product offerings are tailored to sectors requiring microbial biofilm analysis, such as crop protection and medical device development, with AgreGuard-1 and InnovoSIL products specifically addressing antimicrobial needs in agriculture and medical applications. The company monetizes its proprietary technology through direct sales of assay kits and antimicrobial silver products, while contract research services provide recurring revenue streams. Clients include research organizations conducting biofilm studies, agricultural businesses using AgreGuard-1 for crop protection, and medical device manufacturers utilizing InnovoSIL for antimicrobial properties. Innovotech’s focus on specialized testing methodologies and branded products ensures consistent demand from niche markets requiring precise biofilm and antimicrobial evaluation.

Frequently asked questions about Innovotech

Converted at the current exchange rate, the Innovotech share trades at 0.04 EUR (0.06 CAD).

The revenue cannot currently be calculated for Innovotech.

The profit cannot currently be calculated for Innovotech.

The P/E ratio cannot be calculated for Innovotech at the moment.

The P/S cannot be calculated for Innovotech currently.

The Eulerpool Quality Score for Innovotech is 6/10.

The ISIN of Innovotech is CA45772U1049. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Innovotech is IOT.V. The ticker symbol is used to trade Innovotech shares on the stock exchange.

Fair ValueTerminal
0.05 CAD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CAD
Initial public offering
May 28, 2003
ISIN
CA45772U1049
Cusip
45772U104
Market capitalization
3.54 M CADMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
17.10
P/B Ratio
0.98
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
2.51 %
Last updated Nov 19, 2026, 3:51 AM

Innovotech Peer Group

Innovotech FIGI

IOT:CN · BBG000M5X6V9IOT:CV · BBG000M5X8L6IOT:CJ · BBG000M5ZG18IOT:TV · BBG000M5ZJM9IOT:TN · BBG000M5ZLB6IOT:TG · BBG000M5ZM51IOT:TK · BBG000M5ZMC3IOT:TW · BBG001QLGHX1IOT:DV · BBG003G85YB6IOT:DS · BBG004J9VM80IOT:DG · BBG005XRH4T4IOT:QF · BBG0086KCZZ2

All fundamentals and in-depth analysis of Innovotech

Our stock analysis for Innovotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Innovotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.